SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adeshwar Meditex informs about resignation of CFO

26 Sep 2022 Evaluate

With reference to e-mail received from BSE dated September 26, 2022, in regards to resubmission of Corporate Announcement submitted by the Company dated 24-Sep-2022 01:41:56 pm, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Adeshwar Meditex has informed that the company is in receipt of resignation letter dated September 23, 2022 from Shreyas Sampatkumar Jajoo, Chief Financial Officer (CFO) of the Company resigning from closing hours of September 23, 2022 due to personal reason and enclosed the said letter duly accepted by the company.

The above information is a part of company’s filings submitted to BSE.

Adeshwar Meditex Share Price

18.41 0.00 (0.00%)
27-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×